1-Aminopropanediol, also known as 3-amino-1,2-propanediol, is a colorless, viscous liquid that is used as a precursor in the synthesis of pharmaceuticals, including the antimalarial drug mefloquine. It is also a component of some cosmetics and personal care products. The compound is a chiral molecule, meaning it exists in two mirror-image forms, called enantiomers. Only the (S)-enantiomer of 1-aminopropanediol is pharmacologically active. It is synthesized through the reaction of 1,2-epoxypropane with ammonia. 1-Aminopropanediol is studied due to its biological activity as a potent inhibitor of the enzyme glycogen synthase kinase-3 (GSK-3). GSK-3 is involved in a variety of cellular processes, including the regulation of glucose metabolism, cell growth, and inflammation. Inhibition of GSK-3 has been implicated in the treatment of various diseases, including Alzheimer's disease, type 2 diabetes, and cancer.'
1-aminopropanediol: structure given in first source; RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 73561 |
MeSH ID | M0175034 |
Synonym |
---|
4-04-00-01865 (beilstein handbook reference) |
unii-rh369p864x |
rh369p864x , |
ec 210-475-8 |
1-aminoglycerol |
2,3-dihydroxypropylamine |
wln: z1yq1q |
nsc-67381 |
1-amino-2,3-propanediol |
2,3-propandiol-1-amine |
nsc67381 |
3-amino-1,2-propanediol |
616-30-8 |
1,2-propanediol, 3-amino- |
einecs 210-475-8 |
brn 1719121 |
nsc 67381 |
1-aminopropanediol |
ai3-11002 |
3-aminopropane-1,2-diol |
(+/-)-3-amino-1,2-propanediol, 97% |
AB258BA4-8B6E-4939-A773-6152376CFD23 |
(+/-)-3-amino-1,2-propandiol |
A0628 |
3-aminopropan-1,2-diol |
A19738 |
AKOS005259373 |
3-amino-1,2-propandiol |
1-amino-2,3-dihydroxypropane |
FT-0641054 |
BP-12973 |
FT-0601135 |
FT-0601390 |
AM20100501 |
CL4509 |
(+/-)-3-amino-1,2-propanediol |
(+/-)-3-amino-1,2-dihydroxypropane |
isoserinol |
(rs)-3-amino-1,2-propanediol |
aminopropanediol [inci] |
3-amino-2-hydroxypropanol |
racemic-3-amino-1,2-propanediol |
1-aminopropane-2,3-diol |
3-amino-propan-1,2-diol |
3-amino propane 1,2-diol |
amino-2,3-propanediol |
(2rs)-3-amino-1,2-propanediol |
3-amino-1,2-propane-diol |
1-amino-2,3-propane diol |
3-amino-l,2-propandiol |
n-(2,3-dihydroxy-propyl)-amine |
racemic 1-amino-2,3-propanediol |
racemic 3-aminopropane-1,2-diol |
aminopropan-2,3-diol |
2,3-dihydroxy-propylamine |
3-amino1,2-propanediol |
3-amino-propane-1,2-diol |
(+/-) 3-amino-1,2-propanediol |
(r/s)-3-aminopropane-1,2-diol |
3-amino-1,2-dihydroxypropane |
(rs)-3-amino-1,2-propandiol |
racemic 3-amino-1,2-propanediol |
(+/-)-3-aminopropane-1,2-diol |
2,3-dihydroxy-1-propylamine |
(+/-)3-amino-1,2-propanediol |
1-amino-2,3-propandiol |
J-502215 |
Q-200353 |
STR01210 |
AC-23129 |
mfcd00008140 |
CS-W002040 |
(a+/-)-3-amino-1,2-propanediol |
BCP18703 |
DTXSID30862294 |
EN300-50845 |
Q27288116 |
SB44646 |
SB44645 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (11.95) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |